Stroke Outcomes Luncheon Symposium at the Canadian Stroke Congress (May 25, 2026)
A New Chapter in Secondary Stroke Prevention: Clinical Insights from Phase III FXIa Inhibitor Trials
A New Chapter in Secondary Stroke Prevention: Clinical Insights from Phase III FXIa Inhibitor Trials
Important Notice:
This recording and accompanying slide deck are provided as non-accredited educational resources and will be available on this website until June 2027.
The live symposium was accredited for presentation at the Canadian Stroke Congress on May 25, 2026.
The content reflects information available at the time of the original presentation.
You can view and download the slides here.